Aravind Asokan

Chapel Hill, NC, United States of America

Aravind Asokan

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 180(Granted Patents)


Location History:

  • Chapel Hill, NC (US) (2011 - 2024)
  • Durham, NC (US) (2023 - 2024)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: **Aravind Asokan: Pioneering Innovations in Gene Therapy**

Introduction

Aravind Asokan is an accomplished inventor based in Chapel Hill, North Carolina, with a notable contribution to the field of gene therapy, evidenced by his 15 patents. His work primarily focuses on adeno-associated virus (AAV) vectors and their applications in delivering therapeutic genes, making significant strides in medical technology.

Latest Patents

Among his latest inventions are methods and compositions for dual glycan binding AAV vectors. This innovative approach introduces new glycan binding sites into the AAV capsid protein through specific amino acid substitutions. Another pivotal patent covers methods and compositions for gene transfer across the vasculature, detailing modifications in AAV capsid proteins along with the associated virus vectors. These patents provide essential methods for administering virus vectors to cells or subjects in vivo, which holds significant promise for advancing gene therapy solutions.

Career Highlights

Aravind Asokan has held significant positions at esteemed institutions, including the University of North Carolina at Chapel Hill and the University of Florida Research Foundation, Incorporated. His extensive experience in research and development has facilitated groundbreaking advancements in gene delivery systems, emphasizing the transformative potential of AAV vectors in therapeutic applications.

Collaborations

Throughout his career, Asokan has collaborated with notable professionals, including Richard Jude Samulski and Mavis Agbandje-McKenna. These collaborations have fostered innovation and provided a collaborative platform for exploring various dimensions of AAV technology and its applications in medicine.

Conclusion

Aravind Asokan stands out as a leading inventor in the field of gene therapy, with a strong portfolio of patents that contribute to advancements in medical research. His work on AAV vectors not only showcases his inventive spirit but also highlights the potential for future innovations in therapeutic applications, reinforcing the importance of rigorous scientific inquiry and collaboration in addressing pressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…